Only 3 to 6% of cancer patients who are eligible to participate in a clinical trial do so — resulting in over 90% of cancer patients possibly missing out on potentially life-saving treatments.
That doesn’t have to be you.
Clinical trials provide patients with access to new therapies that could become the future standard of care.